Targeting MAPK in Cancer 2.0

Rovida, Elisabetta; Tusa, Ignazia

doi:10.3390/ijms23105702

Open AccessEditorial

Targeting MAPK in Cancer 2.0

by

Elisabetta Rovida

^*

and

Ignazia Tusa

Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, 50134 Florence, Italy

^*

Author to whom correspondence should be addressed.

Int. J. Mol. Sci. 2022, 23(10), 5702; https://doi.org/10.3390/ijms23105702

Submission received: 11 May 2022 / Accepted: 11 May 2022 / Published: 20 May 2022

(This article belongs to the Special Issue Targeting MAPK in Cancer 2.0)

Download Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Mitogen-activated protein kinase (MAPK) pathways are prominently involved in the onset and progression of cancer [...]

Share and Cite

MDPI and ACS Style

Rovida, E.; Tusa, I. Targeting MAPK in Cancer 2.0. Int. J. Mol. Sci. 2022, 23, 5702. https://doi.org/10.3390/ijms23105702

AMA Style

Rovida E, Tusa I. Targeting MAPK in Cancer 2.0. International Journal of Molecular Sciences. 2022; 23(10):5702. https://doi.org/10.3390/ijms23105702

Chicago/Turabian Style

Rovida, Elisabetta, and Ignazia Tusa. 2022. "Targeting MAPK in Cancer 2.0" International Journal of Molecular Sciences 23, no. 10: 5702. https://doi.org/10.3390/ijms23105702

APA Style

Rovida, E., & Tusa, I. (2022). Targeting MAPK in Cancer 2.0. International Journal of Molecular Sciences, 23(10), 5702. https://doi.org/10.3390/ijms23105702

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Targeting MAPK in Cancer 2.0

Excerpt

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI